ALT vs ETR · rev $20.0K vs P/E 28, rev $12.95B
Altimmune Inc (ALT) versus Entergy Corporation (ETR) — a side-by-side from cached financials, not a winner call.
Altimmune Inc (ALT) is a biotechnology company listed on US.
Entergy Corporation (ETR) is a utilities - regulated electric company listed on US.
Latest reported ALT revenue for 2024-12-31 was $20.0K. Net income was -$95.1M. Revenue was down 95.3% from 2023-12-31 to 2024-12-31. ALT currently screens at market cap $527.0M.
Latest reported ETR revenue for 2025-12-31 was $12.95B. Net income was $1.77B. Revenue was up 9.0% from 2024-12-31 to 2025-12-31. ETR currently screens at market cap $50.71B and trailing P/E 28.3.
ALT currently screens at market cap $527.0M. ETR currently screens at market cap $50.71B and trailing P/E 28.3.
Not investment advice. Open the ALT and ETR stock pages for the full models.
Not investment advice.